스포츠 의학 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 용도별, 지역별, 부문 예측(2025-2033년)

Sports Medicine Market Growth & Trends:

The global sports medicine market size is expected to reach USD 15.25 billion by 2033, expanding at a CAGR of 8.62% from 2023 to 2033, according to a new report by Grand View Research, Inc. Rising demand for sports medicine, owing to increasing shift from a sedentary lifestyle to a healthy lifestyle by the younger population, and increasing incidences of injuries among fitness enthusiasts are some of the major factors driving industry growth. Increasing career opportunities and a growing inclination toward fitness owing to rising health awareness have increased the number of people choosing sports as a hobby or a career. This, in turn, is expected to increase their chances of incurring injuries.

For instance, according to Standard Children's Health, in the U.S., out of 30 million children and teens participating in sports, about 3.5 million incur injuries. Moreover, about 21% of all traumatic brain injuries are incurred from sports and recreational activities, which are also the leading cause of death from sports-related injuries. In addition, nearly 775,000 children are treated for sports-related injuries in the U.S. every year. Thus, significantly high treatment adoption rates in emerging & developed countries and increasing participation in sports are expected to fuel the growth of the market during the forecast period.

The market for sports medicine includes products such as braces, supports, and compression garments, as well as diagnostic tools and devices, surgical equipment, and rehabilitation products. Growing popularity of sports and fitness activities drives the demand for sports medicine products and services. As more people participate in these activities, the risk of injuries increases, creating the need for various advanced products and services to prevent and treat these injuries.

Wearable devices, such as fitness bands & sensors, play a pivotal role in this technological advancement. They enable real-time monitoring of stress loads, assisting in averting fatigue-induced injuries and ensuring athletes maintain peak performance levels. The market is undergoing a significant transformation, especially in rehabilitation. Innovations such as antigravity treadmills, exoskeletons, and augmented/virtual reality tools are becoming crucial in the recovery process. This comprehensive approach expedites recovery and raises the overall quality of sports medicine, introducing a new era of precise and effective athlete care. For instance, in January 2023, Enovis (DJO, LLC) launched DynaClip Quattro and DynaClip Delta bone staples. They offer foot and ankle surgeons ease of use & procedural efficiency.

Sports Medicine Market Report Highlights:

• The body reconstruction and repair segment accounted for the largest revenue share of 39.22% in 2024.
• The knee segment accounted for the largest revenue share of 30.64% in 2024, aided by rising incidences of knee injuries.
• North America dominated the overall sports medicine market with the largest share of 51.36% in 2024.
• The Asia Pacific region is expected to grow at the fastest rate during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product type outlook
  • 2.2.2. Application outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Sports Medicine Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased participation in sports and physical activities
    • 3.2.1.2. Rising sports-related injuries
    • 3.2.1.3. Increasing technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. The high cost of sports medicine products and services
    • 3.2.2.2. Shortage of qualified sports medicine specialists
• 3.3. Orthopedic Digit Implants: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Regulatory Landscape and Compliance
• 3.5. Impact of the COVID-19 Pandemic

Chapter 4. Sports Medicine Market Segment Analysis, By Product Type, 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Segment Dashboard
• 4.3. Global sports medicine market, by Product Type, 2021 to 2033
• 4.4. Body Reconstruction & Repair
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.4.2. Surgical Equipment
    • 4.4.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.4.3. Soft Tissue Repair
    • 4.4.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.4.4. Bone Reconstruction Devices
    • 4.4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Body Support & Recovery
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. Braces and Other Support Devices
    • 4.5.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. Compression Clothing
    • 4.5.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. Hot & Cold Therapy
    • 4.5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Body Monitoring & Evaluation
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.2. Cardiac
    • 4.6.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.3. Respiratory
    • 4.6.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.4. Hemodynamic
    • 4.6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.5. Musculoskeletal
    • 4.6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6.6. Others
    • 4.6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Accessories
  • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.2. Bandages
    • 4.7.2.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.3. Tapes
    • 4.7.3.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.4. Disinfectants
    • 4.7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.5. Wraps
    • 4.7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7.6. Others
    • 4.7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Sports Medicine Market Segment Analysis, By Application, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Segment Dashboard
• 5.3. Global sports medicine market, by Application, 2021 to 2033
• 5.4. Knees
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Shoulders
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Ankle & Foot
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Back & Spine
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Elbow & Wrist
  • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Hips
  • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Sports Medicine Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Sports Medicine Market Share by Region, 2024 & 2030:
• 6.5. North America
  • 6.5.1. North America sports medicine market, 2021 - 2033 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Scenario
    • 6.5.2.4. U.S. sports medicine market, 2021 - 2033 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Canada sports medicine market, 2021 - 2033 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Mexico sports medicine market, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Scenario
    • 6.6.2.4. UK sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Germany sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. France sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Italy sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Spain sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Scenario
    • 6.6.7.4. Norway sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Regulatory Framework
    • 6.6.8.3. Competitive Scenario
    • 6.6.8.4. Sweden sports medicine market, 2021 - 2033 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Regulatory Framework
    • 6.6.9.3. Competitive Scenario
    • 6.6.9.4. Denmark sports medicine market, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Regulatory Framework
    • 6.7.1.3. Competitive Scenario
    • 6.7.1.4. Japan sports medicine market, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Scenario
    • 6.7.2.4. China sports medicine market, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Scenario
    • 6.7.3.4. India sports medicine market, 2021 - 2033 (USD Million)
  • 6.7.4. Australia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Regulatory Framework
    • 6.7.4.3. Competitive Scenario
    • 6.7.4.4. Australia sports medicine market, 2021 - 2033 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Regulatory Framework
    • 6.7.5.3. Competitive Scenario
    • 6.7.5.4. South Korea sports medicine market, 2021 - 2033 (USD Million)
  • 6.7.6. Thailand
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Regulatory Framework
    • 6.7.6.3. Competitive Scenario
    • 6.7.6.4. Thailand sports medicine market, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Regulatory Framework
    • 6.8.1.3. Competitive Scenario
    • 6.8.1.4. Brazil sports medicine market, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Scenario
    • 6.8.2.4. Argentina sports medicine market, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key Country Dynamics
    • 6.9.1.2. Regulatory Framework
    • 6.9.1.3. Competitive Scenario
    • 6.9.1.4. South Africa sports medicine market, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Regulatory Framework
    • 6.9.2.3. Competitive Scenario
    • 6.9.2.4. Saudi Arabia sports medicine market, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Regulatory Framework
    • 6.9.3.3. Competitive Scenario
    • 6.9.3.4. UAE sports medicine market, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Regulatory Framework
    • 6.9.4.3. Competitive Scenario
    • 6.9.4.4. Kuwait sports medicine market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company Profiles
  • 7.3.1. Smith+Nephew
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Stryker
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Zimmer Biomet
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Arthrex, Inc.
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Enovis (DJO, LLC)
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. DePuy Synthes (Johnson & Johnson)
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. CONMED Corporation
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Mueller Sports Medicine, Inc.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Breg, Inc.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Performance Health
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Bauerfeind
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Karl Storz SE & Co. KG
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives